Safety, reactogenicity and immunogenicity of the human rotavirus vaccine in preterm European infants: A randomized phase IIIb study

Pediatric Infectious Disease Journal

Volumn 31, Issue 5, 2012, Pages 487-493

  Omenaca, Felix ^a   Sarlangue, Jean ^b   Szenborn, Leszek ^c   Nogueira, Marta ^d   Suryakiran, Pemmaraju V ^e   Smolenov, Igor V ^e   Han, Htay H ^e  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HÔPITAL PELLEGRIN   (France)

^c WROCLAW MEDICAL UNIVERSITY   (Poland)

^d Maternidade Alfredo da Costa   (Portugal)

^e GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

Gastroenteritis; Gestational age; Transplacental antibody transfer

Indexed keywords

IMMUNOGLOBULIN A; PLACEBO; ROTAVIRUS VACCINE;

ABDOMINAL PAIN; ANOREXIA; ARTICLE; BRONCHIOLITIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEHYDRATION; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPE; FEMALE; FEVER; GEOMETRY; GESTATIONAL AGE; HUMAN; HYPERNATREMIA; IMMUNOGENICITY; INFANT; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; PHASE 3 CLINICAL TRIAL; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGISTRATION; ROTAVIRUS; ROTAVIRUS INFECTION; SEROCONVERSION; SIDE EFFECT; STRATIFIED SAMPLE; UPPER RESPIRATORY TRACT INFECTION; VACCINATION REACTION; VIRAL GASTROENTERITIS; VOMITING; WILD TYPE;

ANTIBODIES, VIRAL; DOUBLE-BLIND METHOD; EUROPE; FEMALE; GASTROENTERITIS; GESTATIONAL AGE; HUMANS; IMMUNIZATION SCHEDULE; IMMUNOGLOBULIN A; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; TREATMENT OUTCOME; VACCINATION; VACCINES, ATTENUATED;

EID: 84860239982     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182490a2c     Document Type: Article

References (22)

1. Payne DC, Staat MA, Edwards KM, et al. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States. Pediatrics. 2008;122:1235-1243.
2. Centers for Disease Control and Prevention (CDC). Rotavirus surveillance-worldwide, 2001-2008. MMWR Morb Mortal Wkly Rep. 2008;57:1255-1257.
3. Rotavirus vaccines. WHO Position paper. Wkly Epidemiol Rec. 2007;82:285-296.
4. Bernstein DI, Smith VE, Sherwood JR, et al. Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12. Vaccine. 1998;16:381-387.
5. Vesikari T, Karvonen A, Prymula R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet. 2007;370:1757-1763.
6. Ruiz-Palacios GM, Paez-Schael I, Velquez FR, et al.; Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11-22.
7. Phua KB, Lim FS, Lau YL, et al. Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomised, doubleblind, controlled study. Vaccine. 2009;27:5936-5941.
8. Correia JB, Patel MM, Nakagomi O, et al. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil. J Infect Dis. 2010;201:363-369.
9. Newman RD, Grupp-Phelan J, Shay DK, et al. Perinatal risk factors for infant hospitalization with viral gastroenteritis. Pediatrics. 1999;103:E3.
10. Davis RL, Rubanowice D, Shinefield HR, et al. Immunization levels among premature and low-birth-weight infants and risk factors for delayed up-todate immunization status. Centers for Disease Control and Prevention Vaccine Safety Datalink Group. JAMA. 1999;282:547-553.
11. Langkamp DL, Hoshaw-Woodard S, Boye ME, et al. Delays in receipt of immunizations in low-birth-weight children: a nationally representative sample. Arch Pediatr Adolesc Med. 2001;155:167-172.
12. Committee on Infectious Diseases; American Academy of Pediatrics. Prevention of rotavirus disease: updated guidelines for use of rotavirus vaccine. Pediatrics. 2009;123:1412-1420.
13. Cortese MM, Parashar UD; Centers for Disease Control and Prevention (CDC). Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2009;58(RR-2):1-25.
14. Van Doorn LJ, Kleter B, Hoefnagel E, et al. Detection and genotyping of human rotavirus VP4 and VP7 genes by reverse transcriptase PCR and reverse hybridization. J Clin Microbiol. 2009;47:2704-2712.
15. Goveia MG, Rodriguez ZM, Dallas MJ, et al.; REST Study Team. Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants. Pediatr Infect Dis J. 2007;26:1099-1104.
16. Cheuvart B, Friedland LR, Abu-Elyazeed R, et al. The human rotavirus vaccine RIX4414 in infants: a review of safety and tolerability. Pediatr Infect Dis J. 2009;28:225-232.
17. Phua KB, Quak SH, Lee BW, et al. Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants. J Infect Dis. 2005;192(suppl 1):S6-S16.
18. Vesikari T, Karvonen A, Prymula R, et al. Immunogenicity and safety of the human rotavirus vaccine Rotarix co-administered with routine infant vaccines following the vaccination schedules in Europe. Vaccine. 2010;28:5272-5279.
19. Huang LM, Chang LY, Tsou TP, et al. Immunogenicity of RIX4414 (Rotarix ™), an oral human rotavirus vaccine, in premature infants from Taiwan. Presented at: The World Congress for Pediatric Infectious Diseases, November 15-18, 2007; Bangkok.
20. Bonhoeffer J, Siegrist CA, Heath PT. Immunisation of premature infants. Arch Dis Child. 2006;91:929-935.
21. Chan J, Nirwati H, Triasih R, et al. Maternal antibodies to rotavirus: could they interfere with live rotavirus vaccines in developing countries? Vaccine. 2011;29:1242-1247.
22. Vesikari T, Van Damme P, Giaquinto C, et al. European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology, and Nutrition evidence-based recommendations for rotavirus vaccination in Europe. J Pediatr Gastroenterol Nutr. 2008;46(suppl 2): S81-S122.